Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xinfeng Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer and a key subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company focuses on the research, development, and large-scale production of chemical drug preparations and traditional Chinese medicine (TCM) products. Its diverse portfolio addresses several major therapeutic areas, including cardiovascular health, respiratory diseases, and metabolic disorders, often marketed under the well-recognized "Xinfeng" brand. Operating modern, GMP-certified facilities in Shanghai, the company ensures high-quality standards for both domestic and international markets. As an integral part of the SPH group, Shanghai Xinfeng leverages extensive distribution networks and collaborative R&D resources to maintain its competitive position in the Chinese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xinfeng Pharmaceutical.